These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9648990)

  • 1. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease.
    Griga T; Tromm A; Spranger J; May B
    Scand J Gastroenterol; 1998 May; 33(5):504-8. PubMed ID: 9648990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Gutzeit A; Sommerkamp C; May B
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):175-9. PubMed ID: 10102229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease.
    Bousvaros A; Leichtner A; Zurakowski D; Kwon J; Law T; Keough K; Fishman S
    Dig Dis Sci; 1999 Feb; 44(2):424-30. PubMed ID: 10063933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.
    Griga T; Werner S; Köller M; Tromm A; May B
    Dig Dis Sci; 1999 Jun; 44(6):1196-201. PubMed ID: 10389696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
    Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Hebler U; Voigt E; Tromm A; May B
    Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
    Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
    Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
    Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
    Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.
    Algaba A; Linares PM; Encarnación Fernández-Contreras M; Figuerola A; Calvet X; Guerra I; de Pousa I; Chaparro M; Gisbert JP; Bermejo F
    Inflamm Bowel Dis; 2014 Apr; 20(4):695-702. PubMed ID: 24562175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating von Willebrand factor in inflammatory bowel disease.
    Stevens TR; James JP; Simmonds NJ; McCarthy DA; Laurenson IF; Maddison PJ; Rampton DS
    Gut; 1992 Apr; 33(4):502-6. PubMed ID: 1582595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.
    Magro F; Araujo F; Pereira P; Meireles E; Diniz-Ribeiro M; Velosom FT
    Dig Dis Sci; 2004 Aug; 49(7-8):1265-74. PubMed ID: 15387356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis.
    Boehme MW; Autschbach F; Zuna I; Scherbaum WA; Stange E; Raeth U; Sieg A; Stremmel W
    Gastroenterology; 1997 Jul; 113(1):107-17. PubMed ID: 9207268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.